Istituto Nazionale Tumori (INT) "Fondazione G. Pascale" di Napoli

Naples 80131

1 studies enrolling now · 2 studies all time

What they study most

Advanced Melanoma, Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Studies at this site

• IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) — Recruiting now
• Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004) — Running, not enrolling